Victrex (LON:VCT – Get Free Report) had its target price upped by equities researchers at Berenberg Bank from GBX 600 to GBX 680 in a research note issued to investors on Wednesday,London Stock Exchange reports. The brokerage presently has a “hold” rating on the stock. Berenberg Bank’s price target suggests a potential upside of 2.26% from the stock’s current price.
Several other research firms have also issued reports on VCT. Canaccord Genuity Group lowered shares of Victrex to a “buy” rating and set a GBX 725 price target for the company. in a research report on Friday, May 15th. JPMorgan Chase & Co. lowered their target price on Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a research note on Wednesday, March 18th. UBS Group restated a “sell” rating and set a GBX 575 target price on shares of Victrex in a report on Monday, May 11th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 595 price target on shares of Victrex in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of GBX 674.29.
Read Our Latest Stock Report on VCT
Victrex Stock Performance
Victrex (LON:VCT – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. The firm had revenue of £147.10 million for the quarter. On average, sell-side analysts anticipate that Victrex will post 73.1078905 EPS for the current fiscal year.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
- Five stocks we like better than Victrex
- Vertex’s Crinetics Deal Balances Growth with Integration Risk
- Stacking Chips: The Hidden Supply Shock Fueling Intel
- Drone Stocks Are Down, But Defense Backlogs Tell a Different Story
- Industrials Are Leading in 2026, But These ETFs Take Different Routes
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
